Results 21 to 30 of about 1,348,486 (207)

End of induction treatment outcomes with a novel cyclophosphamide-based regimen for severe lupus nephritis: Single-center experience from South India

Indian Journal of Rheumatology, 2020
Background: Cyclophosphamide is commonly used along with pulse steroids for induction immunosuppression treatment of severe forms of lupus nephritis (LN).
V Jayaprakash, T Dineshkumar, J Dhanapriya, D Rajasekar, R Sakthirajan, T Balasubramaniyan, Anila A Kurien, N Gopalakrishnan   +7 more
doaj   +1 more source

Successful treatment of idiopathic retroperitoneal fibrosis with combined immunosuppressive therapy [PDF]

Vojnosanitetski Pregled, 2019
Background/Aim. Idiopathic retroperitoneal fibrosis (IRF) is characterized by the fibroinflammatory periaortic tissue that affects the ureters, causing obstructive nephropathy and variable impairment of renal function.
Obrenčević Katarina, Petrović Dejan, Aleksić Predrag, Petrović Marijana, Rančić Nemanja, Jovanović Dragan, Nikolić Bojan, Mijušković Mirjana, Vavić Neven, Ignjatović Ljiljana, Maksić Đoko   +10 more
doaj   +1 more source

Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis

The Saudi Journal of Gastroenterology, 2017
Background/Aims: Treatment of refractory ulcerative colitis (UC) is a clinical challenge, and after biological therapy, monitoring clinical and endoscopic responses is fundamental.
Elham A Hassan, Haidi K Ramadan, Ali A Ismael, Khaled F Mohamed, Madiha M El-Attar, Ihab Alhelali   +5 more
doaj   +1 more source

Experience with FLT3 Inhibitor Midostaurin in Newly Diagnosed Acute Myeloid Leukemia Patients

Turkish Journal of Internal Medicine, 2021
Introduction With the introduction of FLT3 inhibitors in recent years, the presence of FLT3 mutation in newly diagnosed acute myeloid leukemia (AML) patients has become more important.
Mehmet Baysal, Nihan Alkis, Serap Baysal
doaj   +1 more source

Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy [PDF]

International Journal of Hematology-Oncology and Stem Cell Research, 2004
Intensive induction therapy-in acute myeloid leukemia (AML), as in some other systemic malignancies- is a strategy fundamentally different from post-remission strategies.
Thomas Büchner, Wolfgang Hiddemann, Wolfgang E. Berdel, Bernhard Wörmann, Helmut Löffler, Claudia Schoch, Torsten Haferlach, Wolf-Dieter Ludwig, Georg Maschmeyer, Eva Lengelder, Peter Staib, Reinhard Andreesen, Leopold Balleisen, Detlef Haase, Hartmut Eimermacher, Andrea Schumacher, Carlo Aul, Herbert Rasche, Jens Uhlig, Andreas Grüneisen, Hans Edgar Reis, Joachim Hartlapp, Wolf-Dietrich Hirschmann, Hans-Josef Weh, Hermann-Josef Pielken, Winfried Gassmann, Maria-Cristina Sauerland, Achim Heinecke for the German AML Cooperative Group   +27 more
doaj   +2 more sources

Intracranial menigioma manifested after delivery in a patient with Hodgkin's disease [PDF]

Vojnosanitetski Pregled, 2006
Background. Intracranial meningioma is rarely reported in the patients treated for Hodgkin’s disease (HD), known to mainly occur in the area of radiation therapy. Case report.
Nagulić Mirjana, Tukić Ljiljana, Ilić Srbislav, Marković Marko   +3 more
doaj   +1 more source

Current concepts of radioimmonotherapy for lymphoma [PDF]

Vojnosanitetski Pregled, 2015
nema
Mihailović Jasna, Ubavić Milan, Trifunović Jasna   +2 more
doaj   +1 more source

The long-term remission of rheumatoid arthritis with a single cycle of rituximab [PDF]

Vojnosanitetski Pregled, 2012
Introduction. Rituximab selectively targets CD20+ B cells and presumably protects joints in rheumatoid arthritis. Complete remissions after a single treatment with rituximab, in some cases for longer than 1 year, are observed in only the minority of ...
Glišić Branislava, Knežević Bojana
doaj   +1 more source

Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review

Arthritis Research & Therapy, 2023
Background To determine the prevalence of sustained remission/low disease activity (LDA) in patients with rheumatoid arthritis (RA) after discontinuation of tumor necrosis factor inhibitors (TNFi), separately in induction treatment and maintenance ...
Michael M. Ward, Nima Madanchi, Ali Yazdanyar, Nehal R. Shah, Florina Constantinescu   +4 more
doaj   +1 more source

EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Arquivos de Gastroenterologia, 2017
BACKGROUND There is evidence that shows that calcineurin inhibitors may be useful for the treatment of severe ulcerative colitis. However, evidence regarding the efficacy of tacrolimus for remission induction in this setting is scarce.
Juan LASA, Pablo OLIVERA
doaj   +1 more source